Envoy Medical (COCH) Debt Ratio (2021 - 2025)

Envoy Medical (COCH) posted Debt Ratio of 0.94 for Q2 2025, down 57.78% sequentially from 2.22 in Q1 2025, and up 153.15% YoY from 0.37 in Q2 2024.

Envoy Medical (COCH) Debt Ratio (2021 - 2025) Analysis & Trends

Envoy Medical has reported Debt Ratio for 4 years, with the latest figure at 0.94 in Q2 2025.

Quarterly Debt Ratio rose 153.15% year-over-year to 0.94 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.94 (up 153.15% YoY) and the FY2024 annual result came in at 0.81, changed N/A from the prior year.
Debt Ratio slipped to 0.94 in Q2 2025 per COCH's latest filing, from 2.22 in the prior quarter.
Over five years, Debt Ratio peaked at 2.22 in Q1 2025 and troughed at 0.0 in Q1 2021.
A 4-year average of 0.74 and a median of 0.59 in 2024 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2024 and 2025: Debt Ratio jumped 1863.12% in 2024, then soared 153.15% in 2025.
Over 4 years, Debt Ratio stood at 0.0 in 2021, then surged by 17840.57% to 0.08 in 2023, then surged by 939.54% to 0.81 in 2024, then advanced by 16.12% to 0.94 in 2025.
According to Business Quant data, Debt Ratio over the past three periods registered 0.94, 2.22, and 0.81 for Q2 2025, Q1 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.30
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.31
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.30
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.04
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.28
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.18
10	Envoy Medical	77.82 Mn	58.14 Mn	-227,000.00	-

Download Data